The global compressor oil market is experiencing robust expansion, driven by surging demand from manufacturing, automotive, ...

Imaging data from the phase 2 MINDFuL trial in Alzheimer’s Disease should be released in Q4 2025. Final data on the INKmune CARE-PC trial is expected in Q4 2025. Financial Results for the Third ...

In a select group of companies is standing out for their exceptional contributions to innovation growth and industry ...

Our blueprint unfolds in four overlapping phases—each grounded in neuroscience, real-world examples, and scalable digital ...

Ariel Investments reports a 20.76% Q3 surge for Ariel Focus Fund, led by smart stock picks. Explore undervalued opportunities ...

Tens of thousands of B.C. public school students are embarking on new tech-based projects thanks to $150,000 from Simon Fraser University aimed at transforming classroom experience. The 2025 ...

JNCASR, Bengaluru, has opened applications for its 2025 Research Programmes in Science and Engineering, including PhD and MS ...

A judge's new ruling against a Pentagon department support military parents who claimed the school system “whitewashed ...

INKmune is a pharmaceutical-grade ... target the innate immune system to fight disease. INmune Bio has three product platforms: the Dominant-Negative Tumor Necrosis Factor (DN-TNF) product platform ...

Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy ...

SMIFS said that BHEL is positioned to benefit from India’s ambitious capacity-addition cycle across thermal, renewable and ...